{"name":"Hangzhou Polymed Biopharmaceuticals, Inc.","slug":"hangzhou-polymed-biopharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNNVF1QWFHMzlsLVg3UEU2NUFqalY0WmpQRGxrdWt6XzduZ1B3aXpOLWlKczQ0OWE1Q2QwbFlOVU9DcktxYUZoQmdzcERXSWI3NVlRNVhqeFM4MkMzV096X3FVR2Y4Rlp5VWlGVkwyd3BPZjhCMGFzLThKSFNqRTQ1eEhaNUhfdG1EQjhNUXhCczJ3anVvaUlIRFYwOUpwdUQtazNxSW1QcG4zUmFnQVJUSlVQT3Q?oc=5","date":"2025-09-01","type":"pipeline","source":"BioSpectrum Asia","summary":"Unlocking the Undruggable with Targeted Protein Degradation - BioSpectrum Asia","headline":"Unlocking the Undruggable with Targeted Protein Degradation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgJBVV95cUxQRmRpYUZmdUl1LU1NdnJ2UEpFdjZSMkFwX1lycDNHT2dMVUt0YUZ6QjNyejg0X0Q2dk5MTXcyTkNsYl9yWl9ZQTlGVmowc0UzdlMtS2MyckYzMEsteHVpdS01UHpUMnBjY1RwTW1SWFBZcHd1UFFWX2IwMV9ydXpIMWozOFVOdk9BSVc2Q29NLVZGOG5OQkhxTXF6dUpWXzR4NE1MaFNSVnpaSlVKWWRzYVd1LXJMMGhKbHFITHZKZk1NTGhCOFlwVm9QY1RkVFFaYlZlTTUwbFhWUXAzNWhBeGFwa2llenRDX2ZkeDdTb3NOWVdRU19DdUlUUFNhVi1aeVZPQ2FzRUxnR1lwRFpyWERCZjF4UW9IWUQ0cFR6a3gxYXVzajMybmVac2xvSWszTC1vb0dzSUg5MldVWnJmV0VwYkxweFFUNHZNTmpn?oc=5","date":"2025-02-20","type":"deal","source":"GlobeNewswire","summary":"Photys Therapeutics Enters into Exclusive License Agreement - GlobeNewswire","headline":"Photys Therapeutics Enters into Exclusive License Agreement","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}